# Assessment of chest CT abnormalities and pulmonary function at 6-month and 1-year after hospital discharge in Chinese patients of COVID-19 pneumonia at the turn of 2022–2023

**Authors:** Xingyu Fang, Jialin Li, Yijun Zhang, Wei Lv, Lin Liu, Yun Feng, Li Liu, Feng Pan, Jinping Zhang

PMC · DOI: 10.3389/fmed.2025.1463320 · 2025-02-26

## TL;DR

This study tracked lung CT scans and function in Chinese patients recovering from COVID-19 pneumonia over one year, finding that lung abnormalities decreased but fibrosis increased and affected lung function.

## Contribution

The study provides longitudinal data on CT abnormalities and pulmonary function in post-COVID-19 patients during the 2022–2023 China epidemic.

## Key findings

- Pulmonary abnormalities decreased from 100% to 37.8% over one year, while fibrotic changes increased.
- Fibrotic changes were strongly correlated with reduced diffusion capacity of the lung for carbon monoxide (DLCO).
- DLCO was significantly lower in patients with fibrotic changes compared to those without.

## Abstract

This study aimed to assess chest CT abnormalities and pulmonary function at 6-month and 1-year follow-ups in coronavirus disease 2019 (COVID-19) pneumonia patients of the China epidemic in the turn of 2022–2023.

A total of 156 hospitalized patients with COVID-19 pneumonia admitted between 29 November 2022 and 10 February 2023 were prospectively assessed at 6-month and 1-year follow-ups. Characteristics and CT scores of pulmonary abnormalities and pulmonary function were compared between different follow-up time points. The correlation of CT abnormalities and pulmonary function at 1-year were evaluated.

Over 1 year, the proportion of pulmonary abnormalities gradually decreased (initial, 100%, 156/156; 6-month, 57.1%, 89/156; and 1-year, 37.8%, 59/156; P < 0.001), whereas fibrotic changes increased (initial, 6.4%, 10/156; 6-month, 14.1%, 22/156; and 1-year, 14.7%, 23/56; P < 0.001). Compared to participants of the subgroup with nonfibrotic changes, diffusion capacity of the lung for carbon monoxide (DLCO)(P = 0.01) and DLCO less than 80% predicted (P < 0.001) showed significantly decrease in participants of the subgroup with fibrotic changes. The extent of fibrotic changes was strongly correlated with lower DLCO (r = −0.734, P < 0.001).

Fibrotic changes might show a tendency to persist over time and correlate strongly with impairment of diffusion function, thus requiring more attention in future follow-ups.

## Linked entities

- **Diseases:** coronavirus disease 2019 (MONDO:0100096), pneumonia (MONDO:0005249)

## Full-text entities

- **Diseases:** COVID-19 pneumonia (MESH:D000086382), pneumonia (MESH:D011014), chest CT abnormalities (MESH:D002637), CT abnormalities (MESH:D000014), pulmonary function (OMIM:608852), pulmonary abnormalities (MESH:D008171)
- **Chemicals:** carbon (MESH:D002244)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11896869/full.md

---
Source: https://tomesphere.com/paper/PMC11896869